| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |

,
,
* From the Department of Anaesthesia, St. Joseph's Hospital, the
Departments of Pathology and Molecular Medicine and
Paediatrics, McMaster University,
Hamilton, Ontario, Canada.
Address correspondence to: Dr. Peter T.-L. Choi, Department of Anaesthesia, McMaster University, HSC-2U7, 1200 Main Street West, Hamilton, Ontario, L8N 3Z5 Canada. Phone: 905-521-2100; Fax: 905-523-1224; E-mail: choip{at}fhs.csu.mcmaster.ca
| Abstract |
|---|
|
|
|---|
Clinical features: Three patients diagnosed with SLOS at McMaster University underwent a total of five anesthetics for diagnostic imaging and surgical procedures. The age of the patients ranged from two months to four years. Four intravenous anesthetics and one balanced general anesthetic were administered. One patient was noted to have a diminished laryngoscopic view but no difficult intubations were encountered. One patient required re-intubation due to upper airway obstruction related to the surgical procedure in the postoperative period. No cardiovascular, respiratory, or temperature complications were experienced.
Conclusion: This report describes the anesthetic management in three patients with SLOS. Although the syndrome raises a number of potential anesthetic concerns, few complications were seen. This is consistent with other cases reported in the literature, which is reviewed in this report.
| Introduction |
|---|
|
|
|---|
7-reductase, which leads to an accumulation of 7-dehydrocholesterol (7-DHC) and generalized cholesterol deficiency.5,6 To confirm the diagnosis of SLOS, it is necessary to demonstrate the elevated plasma levels of 7-DHC. The gene for SLOS has been mapped to chromosome 11q12-13 and mutations in the 7-DHC reductase gene have been demonstrated in patients with SLOS since 1998.6,7 Given the plethora of congenital anomalies, SLOS patients are likely to undergo anesthesia for diagnostic procedures and corrective surgery. In this paper, we report our departments' clinical experience with SLOS patients undergoing anesthesia and review the anesthetic considerations of this syndrome.
| Report of case series |
|---|
|
|
|---|
Patient A
The first patient was a four year old, 15.5 kg boy who underwent an elective magnetic resonance imaging (MRI) scan of his head. He had no other health problems aside from SLOS. Prior to induction of anesthesia, his vital signs were SpO2 98%, HR 98 bpm, BP 70/30 mmHg, and temperature 35.8°C. Induction of anesthesia was achieved with 70 mg propofol. Total intravenous anesthesia (TIVA) with a 200 µgkg1min1 propofol infusion was used for maintenance. The child breathed spontaneously with nasal prongs. The vital signs remained within 90% of the pre-induction values during the uneventful procedure and recovery period.
Patient B
The second patient was the two year old, 11 kg brother of patient A. He too underwent elective MRI scan of his head. Aside from SLOS, he also had gastroesophageal reflux, mild supravalvular aortic stenosis and coarctation, and an aberrant right subclavian artery. His pre-induction vital signs were SpO2 100%, HR 130 bpm, BP 90/40 mmHg, and temperature 36.7°C. Induction of anesthesia and tracheal intubation was achieved with 30 mg propofol and a 4.5 mm oral endotracheal tube (ETT). Anesthesia was maintained with TIVA using a 200 µgkg1min1 propofol infusion and spontaneous ventilation. Vital signs remained with in 90% of pre-induction values throughout the anesthetic and recovery period.
Patient C
The third patient underwent three procedures within her first year of life. The diagnosis of SLOS was made shortly after birth. She also had a cleft palate and recurrent aspirations. At two months of age, when she weighed 2.7 kg, the patient underwent endoscopic percutaneous insertion of a gastrostomy tube. Preoperative vital signs were SpO2 100%, HR 140 bpm, BP 90/60 mmHg, and temperature 36.5°C. An inhalational induction was performed with halothane 5% and oxygen 100% along with cricoid pressure. Upon laryngoscopy, the posterior arytenoids were visualized and the trachea was intubated with a 3.5 mm oral ETT. Balanced general anesthesia was maintained with 1 to 2 MAC isoflurane, 2 Lmin-1 N2O, 2 Lmin-1 O2, and boluses of rocuronium along with intermittent positive pressure ventilation (IPPV). Analgesia was obtained by infiltration of the gastrostomy site with local anesthetic. Vital signs were SpO2 95%, HR 150 to 190 bpm, BP 120/60 mmHg, and temperature 36.9°C during the one hour procedure and returned to pre-induction values during recovery.
Two months later, the patient underwent a MRI scan of her head. Her weight was 2.8 kg. Pre-induction vital signs were similar to her first procedure. Induction of anesthesia was accomplished with 10 mg propofol. Laryngoscopic view remained unchanged and the trachea was intubated with a 3.5 mm oral ETT. Maintenance of anesthesia was with 2 Lmin-1 N2O and 2 Lmin-1 O2 along with 10 mg propofol boluses every 15 min. Pressure controlled ventilation with 15 cmH2O ventilating pressure and 5 cmH2O positive end-expiratory pressure at 30 breathsmin-1 were used. Vital signs remained within 90% of pre-induction values during the procedure and recovery period.
At ten months of age, the patient underwent tonsillectomy and cleft palate repair. She was now 4.1 kg with vital signs of SpO2 98%, HR 160 bpm, BP 80/50 mmHg, and temperature 36.5°C. After premedication with 0.1 mg atropine, induction of anesthesia and tracheal intubation was with 30 mg propofol and a 4.0 mm oral ETT. This time, only the epiglottis could be seen with laryngoscopy but intubation was successful on the first attempt. Anesthesia was maintained with 700 mLmin-1 N2O, 300 mLmin-1 O2, 150 to 200 µgkg1min1 propofol infusion, and intermittent 1 µgkg1 fentanyl boluses along with IPPV with a tidal volume of 100 mL at 15 breathsmin-1. Again, vital signs were maintained within 90% of the preoperative values during the procedure. During the recovery period, the patient required O2 70% to maintain her SpO2 > 90%. Five hours after surgery, the patient required re- intubation due to upper airway obstruction from localized tissue edema and she was admitted to the intensive care unit, where she made an eventual uneventful recovery.
| Discussion |
|---|
|
|
|---|
|
|
|
Concerns also exist regarding difficult intubation in patients with SLOS. Prominent incisors, micrognathia (67 to 100 %), and tongue abnormalities (12 to 63 %) have been observed.2,8 In addition, palatal abnormalities are common (78 %).2 Cleft palate (37 to 68 %) and high arched palate are frequently seen.2,8 These anatomic features may increase the difficulty of laryngoscopy and tracheal intubation. In our series, one patient had an abnormal laryngoscopic view, which worsened with age; however, intubation was not difficult. Haji-Michael et al.12 also reported one difficult intubation but no further detail was provided.
In addition to a potentially difficult airway, cardiorespiratory problems further complicate anesthesia in patients with SLOS. The majority of respiratory complications seen in SLOS are the result of aspiration due to gastroesophageal reflux, pyloric stenosis, or Hirschsprung's disease.2 Congenital pulmonary anomalies such as hypoplastic or incomplete lobulation of the lungs (25 to 56 percent)2,14 result in diminished lung volumes and can further complicate anesthesia. Congenital heart disease affects 37 to 84 % of patients.2,14,15 The commonest cardiac lesions in SLOS are those with abnormal intracardiac blood flow (secundum type atrial septal defects, ventricular septal defects, the hypoplastic left heart syndrome spectrum, and patent ductus arteriosus).14
Apart from the anatomical and physiological considerations of SLOS, anesthesia can also be difficult as patients with SLOS may display uncooperative behaviour.4 In one case series, 53 % of patients exhibited aggressive behaviour.2
Given the concerns outlined above, patients with SLOS who undergo anesthesia should be assessed by an anesthesiologist and a clinical geneticist before surgery. Detailed airway and cardiorespiratory examinations are necessary to delineate the extent of abnormality in these systems. Although there have been no reports of failed intubation, a high index of suspicion for difficult intubation should be maintained. Aspiration and endocarditis prophylaxis may be required depending on the clinical findings and on the surgical procedure. The decision regarding the avoidance of MH triggering agents during anesthesia is controversial since there is insufficient evidence to support or refute an association between SLOS and MH. Perioperative temperature monitoring should be utilized. Malignant hyperthermia should be considered if a patient develops rigidity, respiratory acidosis, temperature increase, or cardiac dysrhythmias in the presence of triggering agents.
In summary, we report three patients with SLOS undergoing anesthesia. This rare genetic syndrome raises a number of anesthetic concerns including possible MH susceptibility, difficult airway, aspiration risk, and hemodynamic complications from congenital cardiac disease. Although careful assessment is necessary, the current literature reports few serious complications in patients with SLOS.
| Acknowledgments |
|---|
Accepted for publication February 12, 2000.
| References |
|---|
|
|
|---|
2 Ryan AK, Bartlett K, Clayton P, et al. Smith-Lemli-Opitz syndrome: a variable clinical and biochemical phenotype. J Med Genet 1998; 35: 55865.[Abstract]
3 Nowaczyk MJM, Whelan DT, Hill RE. Smith-Lemli-Opitz syndrome: phenotypic extreme with minimal clinical findings. Am J Med Genet 1998; 78: 41923.[Medline]
4
Nowaczyk MJM, Whelan DT, Heshka TW, Hill RE. Smith-Lemli-Opitz syndrome: a treatable inherited error of metabolism causing mental retardation. CMAJ 1999; 161: 16570.
5
Tint GS, Irons M, Elias ER, et al. Defective cholesterol biosynthesis associated with the Smith-Lemli-Opitz syndrome. N Engl J Med 1994; 330: 10713.
6 Wassif CA, Maslen C, Kechilele-Linjwile S, et al. Mutations in the human sterol 7-reductase gene at 11q12-13 cause Smith-Lemli-Opitz syndrome. Am J Hum Genet 1998; 63: 5562.[Medline]
7 Waterham HR, Wijburg FA, Hennekam RCM, et al. Smith-Lemli-Opitz syndrome is caused by mutations in the 7-dehydrocholesterol reductase gene. Am J Hum Genet 1998; 63: 32938.[Medline]
8 Opitz JM. RSH (so-called Smith-Lemli-Opitz) syndrome. Curr Opin Pediatr 1999; 11: 35362.[Medline]
9 Komatsu H, Tosaki Y, Ogli K, Yokono S. Anesthetic management of a patient with Smith-Lemli-Opitz syndrome. (Japanese) Masui 1987; 36: 14503.
10 Mizushima A, Satoyoshi M. Unusual responses of muscle rigidity and hypothermia to halothane and succinylcholine; a case report of Smith-Lemli-Opitz (SLO) syndrome. (Japanese) Masui 1988; 37: 111823.
11 Petersen WC, Crouch ER Jr. Anesthesia-induced rigidity, unrelated to succinylcholine, associated with Smith-Lemli-Opitz syndrome and malignant hyperthermia. Anesth Analg 1995; 80: 6068.[Medline]
12 Haji-Michael PG, Hatch DL. Smith-Lemli-Opitz syndrome and malignant hyperthermia (Letter). Anesth Analg 1996; 83: 200.
13 Larach MG, Localio AR, Allen GC, et al. A clinical grading scale to predict malignant hyperthermia susceptibility. Anesthesiology 1994; 80: 7719.[Medline]
14 Lin AE, Ardinger HH, Ardinger RH Jr, Cunniff C, Kelley RI. Cardiovascular malformations in Smith- Lemli-Opitz syndrome. Am J Med Genet 1997; 68: 2708.[Medline]
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |